ID   BOP1_HUMAN              Reviewed;         746 AA.
AC   Q14137; Q969Z6; Q96IS8; Q96Q25; Q9BSA7; Q9BVM0;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   10-OCT-2002, sequence version 2.
DT   28-JUN-2023, entry version 220.
DE   RecName: Full=Ribosome biogenesis protein BOP1 {ECO:0000255|HAMAP-Rule:MF_03027};
DE   AltName: Full=Block of proliferation 1 protein {ECO:0000255|HAMAP-Rule:MF_03027};
GN   Name=BOP1 {ECO:0000255|HAMAP-Rule:MF_03027}; Synonyms=KIAA0124;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=11237751; DOI=10.1006/bbrc.2001.4377;
RA   Nakatsura T., Senju S., Yamada K., Jotsuka T., Ogawa M., Nishimura Y.;
RT   "Gene cloning of immunogenic antigens overexpressed in pancreatic cancer.";
RL   Biochem. Biophys. Res. Commun. 281:936-944(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Gloeckner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C.J., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, Eye, Lymph, Muscle, and Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 65-746 (ISOFORM 1).
RC   TISSUE=Bone marrow;
RX   PubMed=8590280; DOI=10.1093/dnares/2.4.167;
RA   Nagase T., Seki N., Tanaka A., Ishikawa K., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. IV. The
RT   coding sequences of 40 new genes (KIAA0121-KIAA0160) deduced by analysis of
RT   cDNA clones from human cell line KG-1.";
RL   DNA Res. 2:167-174(1995).
RN   [5]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=12429849; DOI=10.1091/mbc.e02-05-0271;
RA   Scherl A., Coute Y., Deon C., Calle A., Kindbeiter K., Sanchez J.-C.,
RA   Greco A., Hochstrasser D.F., Diaz J.-J.;
RT   "Functional proteomic analysis of human nucleolus.";
RL   Mol. Biol. Cell 13:4100-4109(2002).
RN   [6]
RP   INTERACTION WITH PES1 AND WDR12, AND INDUCTION.
RX   PubMed=16043514; DOI=10.1083/jcb.200501141;
RA   Hoelzel M., Rohrmoser M., Schlee M., Grimm T., Harasim T., Malamoussi A.,
RA   Gruber-Eber A., Kremmer E., Hiddemann W., Bornkamm G.W., Eick D.;
RT   "Mammalian WDR12 is a novel member of the Pes1-Bop1 complex and is required
RT   for ribosome biogenesis and cell proliferation.";
RL   J. Cell Biol. 170:367-378(2005).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-106, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [9]
RP   INTERACTION WITH PES1 AND WDR12.
RX   PubMed=16738141; DOI=10.1093/nar/gkl378;
RA   Grimm T., Hoelzel M., Rohrmoser M., Harasim T., Malamoussi A.,
RA   Gruber-Eber A., Kremmer E., Eick D.;
RT   "Dominant-negative Pes1 mutants inhibit ribosomal RNA processing and cell
RT   proliferation via incorporation into the PeBoW-complex.";
RL   Nucleic Acids Res. 34:3030-3043(2006).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH PES1 AND WDR12.
RX   PubMed=17353269; DOI=10.1128/mcb.00172-07;
RA   Rohrmoser M., Hoelzel M., Grimm T., Malamoussi A., Harasim T., Orban M.,
RA   Pfisterer I., Gruber-Eber A., Kremmer E., Eick D.;
RT   "Interdependence of Pes1, Bop1, and WDR12 controls nucleolar localization
RT   and assembly of the PeBoW complex required for maturation of the 60S
RT   ribosomal subunit.";
RL   Mol. Cell. Biol. 27:3682-3694(2007).
RN   [11]
RP   INTERACTION WITH PES1 AND WDR12.
RX   PubMed=17189298; DOI=10.1093/nar/gkl1058;
RA   Hoelzel M., Grimm T., Rohrmoser M., Malamoussi A., Harasim T.,
RA   Gruber-Eber A., Kremmer E., Eick D.;
RT   "The BRCT domain of mammalian Pes1 is crucial for nucleolar localization
RT   and rRNA processing.";
RL   Nucleic Acids Res. 35:789-800(2007).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-106; SER-126 AND SER-127, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by enrichment
RT   and fractionation of phosphopeptides with strong anion exchange
RT   chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-126 AND SER-127, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-126 AND SER-127, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-126 AND SER-127, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [20]
RP   FUNCTION.
RX   PubMed=24120868; DOI=10.1016/j.celrep.2013.08.049;
RA   Sloan K.E., Bohnsack M.T., Watkins N.J.;
RT   "The 5S RNP couples p53 homeostasis to ribosome biogenesis and nucleolar
RT   stress.";
RL   Cell Rep. 5:237-247(2013).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-126 AND SER-127, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-122; SER-126 AND SER-127, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [23]
RP   INTERACTION WITH DDX27.
RX   PubMed=25825154; DOI=10.1016/j.yexcr.2015.03.017;
RA   Kellner M., Rohrmoser M., Forne I., Voss K., Burger K., Muehl B.,
RA   Gruber-Eber A., Kremmer E., Imhof A., Eick D.;
RT   "DEAD-box helicase DDX27 regulates 3' end formation of ribosomal 47S RNA
RT   and stably associates with the PeBoW-complex.";
RL   Exp. Cell Res. 334:146-159(2015).
CC   -!- FUNCTION: Component of the PeBoW complex, which is required for
CC       maturation of 28S and 5.8S ribosomal RNAs and formation of the 60S
CC       ribosome. {ECO:0000255|HAMAP-Rule:MF_03027,
CC       ECO:0000269|PubMed:17353269, ECO:0000269|PubMed:24120868}.
CC   -!- SUBUNIT: Component of the PeBoW complex, composed of BOP1, PES1 and
CC       WDR12 (PubMed:16043514, PubMed:16738141, PubMed:17189298,
CC       PubMed:17353269). The complex is held together by BOP1, which interacts
CC       with PES1 via its N-terminal domain and with WDR12 via a high-affinity
CC       interaction between the seven-bladed beta-propeller domains of the 2
CC       proteins. The NOP7 complex associates with the 66S pre-ribosome (By
CC       similarity). The PeBoW complex associates with DDX27, BOP1 interacts
CC       directly with DDX27 (PubMed:25825154). {ECO:0000255|HAMAP-
CC       Rule:MF_03027, ECO:0000269|PubMed:16043514,
CC       ECO:0000269|PubMed:16738141, ECO:0000269|PubMed:17189298,
CC       ECO:0000269|PubMed:17353269, ECO:0000269|PubMed:25825154}.
CC   -!- INTERACTION:
CC       Q14137; O00541: PES1; NbExp=4; IntAct=EBI-1050828, EBI-1053271;
CC       Q14137; Q9GZL7: WDR12; NbExp=3; IntAct=EBI-1050828, EBI-2490660;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000255|HAMAP-
CC       Rule:MF_03027, ECO:0000269|PubMed:12429849}. Nucleus, nucleoplasm
CC       {ECO:0000255|HAMAP-Rule:MF_03027, ECO:0000269|PubMed:12429849}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q14137-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q14137-2; Sequence=VSP_056391;
CC   -!- INDUCTION: By MYC. {ECO:0000269|PubMed:16043514}.
CC   -!- SIMILARITY: Belongs to the WD repeat BOP1/ERB1 family.
CC       {ECO:0000255|HAMAP-Rule:MF_03027}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="https://atlasgeneticsoncology.org/gene/44348/BOP1";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB060694; BAB70666.1; -; mRNA.
DR   EMBL; AC145291; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC231662; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC001086; AAH01086.2; -; mRNA.
DR   EMBL; BC005160; AAH05160.2; -; mRNA.
DR   EMBL; BC007274; AAH07274.1; -; mRNA.
DR   EMBL; BC013787; AAH13787.1; -; mRNA.
DR   EMBL; BC013980; AAH13980.1; -; mRNA.
DR   EMBL; BC017674; AAH17674.1; -; mRNA.
DR   EMBL; D50914; BAA09473.1; -; mRNA.
DR   CCDS; CCDS6418.2; -. [Q14137-1]
DR   RefSeq; NP_056016.1; NM_015201.4. [Q14137-1]
DR   AlphaFoldDB; Q14137; -.
DR   SMR; Q14137; -.
DR   BioGRID; 116850; 179.
DR   ComplexPortal; CPX-2846; PeBoW complex.
DR   CORUM; Q14137; -.
DR   IntAct; Q14137; 46.
DR   MINT; Q14137; -.
DR   STRING; 9606.ENSP00000455106; -.
DR   GlyGen; Q14137; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q14137; -.
DR   PhosphoSitePlus; Q14137; -.
DR   SwissPalm; Q14137; -.
DR   BioMuta; BOP1; -.
DR   DMDM; 23830903; -.
DR   SWISS-2DPAGE; Q14137; -.
DR   EPD; Q14137; -.
DR   jPOST; Q14137; -.
DR   MassIVE; Q14137; -.
DR   MaxQB; Q14137; -.
DR   PaxDb; Q14137; -.
DR   PeptideAtlas; Q14137; -.
DR   ProteomicsDB; 59839; -. [Q14137-1]
DR   ProteomicsDB; 77815; -.
DR   Antibodypedia; 59721; 172 antibodies from 22 providers.
DR   DNASU; 23246; -.
DR   Ensembl; ENST00000569669.6; ENSP00000455106.1; ENSG00000261236.8. [Q14137-1]
DR   Ensembl; ENST00000642409.2; ENSP00000495401.1; ENSG00000285301.2. [Q14137-1]
DR   GeneID; 23246; -.
DR   KEGG; hsa:23246; -.
DR   MANE-Select; ENST00000569669.6; ENSP00000455106.1; NM_015201.5; NP_056016.1.
DR   UCSC; uc033ccj.2; human. [Q14137-1]
DR   AGR; HGNC:15519; -.
DR   CTD; 23246; -.
DR   DisGeNET; 23246; -.
DR   GeneCards; BOP1; -.
DR   HGNC; HGNC:15519; BOP1.
DR   HPA; ENSG00000261236; Tissue enhanced (skeletal).
DR   MIM; 610596; gene.
DR   neXtProt; NX_Q14137; -.
DR   OpenTargets; ENSG00000261236; -.
DR   PharmGKB; PA25398; -.
DR   VEuPathDB; HostDB:ENSG00000261236; -.
DR   eggNOG; KOG0650; Eukaryota.
DR   GeneTree; ENSGT00390000018422; -.
DR   HOGENOM; CLU_011390_0_1_1; -.
DR   InParanoid; Q14137; -.
DR   OMA; MRPAKGE; -.
DR   OrthoDB; 5472008at2759; -.
DR   PhylomeDB; Q14137; -.
DR   TreeFam; TF300437; -.
DR   PathwayCommons; Q14137; -.
DR   Reactome; R-HSA-6791226; Major pathway of rRNA processing in the nucleolus and cytosol.
DR   SignaLink; Q14137; -.
DR   BioGRID-ORCS; 23246; 694 hits in 1159 CRISPR screens.
DR   ChiTaRS; BOP1; human.
DR   GeneWiki; BOP1; -.
DR   GenomeRNAi; 23246; -.
DR   Pharos; Q14137; Tbio.
DR   PRO; PR:Q14137; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; Q14137; protein.
DR   Bgee; ENSG00000261236; Expressed in right lobe of thyroid gland and 95 other tissues.
DR   ExpressionAtlas; Q14137; baseline and differential.
DR   Genevisible; Q14137; HS.
DR   GO; GO:0005694; C:chromosome; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0070545; C:PeBoW complex; IDA:UniProtKB.
DR   GO; GO:0030687; C:preribosome, large subunit precursor; IBA:GO_Central.
DR   GO; GO:1990904; C:ribonucleoprotein complex; IDA:MGI.
DR   GO; GO:0043021; F:ribonucleoprotein complex binding; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0008283; P:cell population proliferation; IEA:Ensembl.
DR   GO; GO:0000448; P:cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); IEA:Ensembl.
DR   GO; GO:0000463; P:maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); IMP:UniProtKB.
DR   GO; GO:0051726; P:regulation of cell cycle; IMP:UniProtKB.
DR   GO; GO:1901796; P:regulation of signal transduction by p53 class mediator; IMP:UniProtKB.
DR   GO; GO:0000027; P:ribosomal large subunit assembly; IMP:UniProtKB.
DR   GO; GO:0042254; P:ribosome biogenesis; NAS:UniProtKB.
DR   Gene3D; 2.130.10.10; YVTN repeat-like/Quinoprotein amine dehydrogenase; 1.
DR   HAMAP; MF_03027; BOP1; 1.
DR   InterPro; IPR028598; BOP1/Erb1.
DR   InterPro; IPR012953; BOP1_N_dom.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   PANTHER; PTHR17605:SF0; RIBOSOME BIOGENESIS PROTEIN BOP1; 1.
DR   PANTHER; PTHR17605; RIBOSOME BIOGENESIS PROTEIN BOP1 BLOCK OF PROLIFERATION 1 PROTEIN; 1.
DR   Pfam; PF08145; BOP1NT; 1.
DR   Pfam; PF00400; WD40; 3.
DR   SMART; SM01035; BOP1NT; 1.
DR   SMART; SM00320; WD40; 7.
DR   SUPFAM; SSF50978; WD40 repeat-like; 1.
DR   PROSITE; PS00678; WD_REPEATS_1; 1.
DR   PROSITE; PS50082; WD_REPEATS_2; 2.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   Ribosome biogenesis; rRNA processing; WD repeat.
FT   CHAIN           1..746
FT                   /note="Ribosome biogenesis protein BOP1"
FT                   /id="PRO_0000050885"
FT   REPEAT          411..450
FT                   /note="WD 1"
FT   REPEAT          452..492
FT                   /note="WD 2"
FT   REPEAT          532..576
FT                   /note="WD 3"
FT   REPEAT          577..615
FT                   /note="WD 4"
FT   REPEAT          618..657
FT                   /note="WD 5"
FT   REPEAT          661..700
FT                   /note="WD 6"
FT   REPEAT          716..746
FT                   /note="WD 7"
FT   REGION          1..116
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          265..427
FT                   /note="Sufficient for nucleolar localization"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        14..28
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        39..66
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        67..86
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         106
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:16964243,
FT                   ECO:0007744|PubMed:18669648"
FT   MOD_RES         122
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         126
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         127
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   VAR_SEQ         1..112
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11237751"
FT                   /id="VSP_056391"
FT   CONFLICT        577
FT                   /note="R -> H (in Ref. 4; BAA09473)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   746 AA;  83630 MW;  49A97BE21B0EB3DD CRC64;
     MAGSRGAGRT AAPSVRPEKR RSEPELEPEP EPEPPLLCTS PLSHSTGSDS GVSDSEESVF
     SGLEDSGSDS SEDDDEGDEE GEDGALDDEG HSGIKKTTEE QVQASTPCPR TEMASARIGD
     EYAEDSSDEE DIRNTVGNVP LEWYDDFPHV GYDLDGRRIY KPLRTRDELD QFLDKMDDPD
     YWRTVQDPMT GRDLRLTDEQ VALVRRLQSG QFGDVGFNPY EPAVDFFSGD VMIHPVTNRP
     ADKRSFIPSL VEKEKVSRMV HAIKMGWIQP RRPRDPTPSF YDLWAQEDPN AVLGRHKMHV
     PAPKLALPGH AESYNPPPEY LLSEEERLAW EQQEPGERKL SFLPRKFPSL RAVPAYGRFI
     QERFERCLDL YLCPRQRKMR VNVDPEDLIP KLPRPRDLQP FPTCQALVYR GHSDLVRCLS
     VSPGGQWLVS GSDDGSLRLW EVATARCVRT VPVGGVVKSV AWNPSPAVCL VAAAVEDSVL
     LLNPALGDRL VAGSTDQLLS AFVPPEEPPL QPARWLEASE EERQVGLRLR ICHGKPVTQV
     TWHGRGDYLA VVLATQGHTQ VLIHQLSRRR SQSPFRRSHG QVQRVAFHPA RPFLLVASQR
     SVRLYHLLRQ ELTKKLMPNC KWVSSLAVHP AGDNVICGSY DSKLVWFDLD LSTKPYRMLR
     HHKKALRAVA FHPRYPLFAS GSDDGSVIVC HGMVYNDLLQ NPLLVPVKVL KGHVLTRDLG
     VLDVIFHPTQ PWVFSSGADG TVRLFT
//
